List of Tables
    Table 1. Erythropoietin Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Erythropoietin Drugs Market Trends
    Table 3. Erythropoietin Drugs Market Drivers
    Table 4. Erythropoietin Drugs Market Challenges
    Table 5. Erythropoietin Drugs Market Restraints
    Table 6. Global Erythropoietin Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Erythropoietin Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Erythropoietin Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Erythropoietin Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Erythropoietin Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Erythropoietin Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Erythropoietin Drugs Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Erythropoietin Drugs Sales by Manufacturer, (K Pcs), 2017-2022
    Table 14. Global Erythropoietin Drugs Sales Share by Manufacturer, 2017-2022
    Table 15. Global Erythropoietin Drugs Price by Manufacturer (2017-2022) & (USD/Pcs)
    Table 16. Global Erythropoietin Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Erythropoietin Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Erythropoietin Drugs as of 2021)
    Table 18. Top Players of Erythropoietin Drugs in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Erythropoietin Drugs Product Type
    Table 20. Date of International Manufacturers Enter into Erythropoietin Drugs Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Erythropoietin Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Erythropoietin Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Erythropoietin Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Erythropoietin Drugs Sales by Players, (K Pcs), 2020, 2021 & 2022
    Table 26. United States Erythropoietin Drugs Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Erythropoietin Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Erythropoietin Drugs Sales in Volume by Region (2017-2022) & (K Pcs)
    Table 29. Global Erythropoietin Drugs Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
    Table 30. Global Erythropoietin Drugs Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Erythropoietin Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Erythropoietin Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 33. North America Erythropoietin Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Erythropoietin Drugs Sales in Volume by Region (2017-2028) & (K Pcs)
    Table 35. Asia Pacific Erythropoietin Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Erythropoietin Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 37. Europe Erythropoietin Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Erythropoietin Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 39. Latin Americaa Erythropoietin Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Erythropoietin Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 41. Middle East and Africa Erythropoietin Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Amgen Corporation Information
    Table 43. Amgen Description and Business Overview
    Table 44. Amgen Erythropoietin Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 45. Amgen Erythropoietin Drugs Product
    Table 46. Amgen Recent Development
    Table 47. Johnson & Johnson Corporation Information
    Table 48. Johnson & Johnson Description and Business Overview
    Table 49. Johnson & Johnson Erythropoietin Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 50. Johnson & Johnson Product
    Table 51. Johnson & Johnson Recent Development
    Table 52. Roche Corporation Information
    Table 53. Roche Description and Business Overview
    Table 54. Roche Erythropoietin Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 55. Roche Product
    Table 56. Roche Recent Development
    Table 57. Galenica Corporation Information
    Table 58. Galenica Description and Business Overview
    Table 59. Galenica Erythropoietin Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 60. Galenica Product
    Table 61. Galenica Recent Development
    Table 62. Emcure Corporation Information
    Table 63. Emcure Description and Business Overview
    Table 64. Emcure Erythropoietin Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 65. Emcure Product
    Table 66. Emcure Recent Development
    Table 67. Kyowa Hakko Kirin Corporation Information
    Table 68. Kyowa Hakko Kirin Description and Business Overview
    Table 69. Kyowa Hakko Kirin Erythropoietin Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 70. Kyowa Hakko Kirin Product
    Table 71. Kyowa Hakko Kirin Recent Development
    Table 72. 3SBio Corporation Information
    Table 73. 3SBio Description and Business Overview
    Table 74. 3SBio Erythropoietin Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 75. 3SBio Product
    Table 76. 3SBio Recent Development
    Table 77. Biocon Corporation Information
    Table 78. Biocon Description and Business Overview
    Table 79. Biocon Erythropoietin Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 80. Biocon Product
    Table 81. Biocon Recent Development
    Table 82. LG Life Sciences Corporation Information
    Table 83. LG Life Sciences Description and Business Overview
    Table 84. LG Life Sciences Erythropoietin Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 85. LG Life Sciences Product
    Table 86. LG Life Sciences Recent Development
    Table 87. Key Raw Materials Lists
    Table 88. Raw Materials Key Suppliers Lists
    Table 89. Erythropoietin Drugs Customers List
    Table 90. Erythropoietin Drugs Distributors List
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Erythropoietin Drugs Product Picture
    Figure 2. Global Erythropoietin Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Erythropoietin Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. Global Erythropoietin Drugs Sales 2017-2028 (K Pcs)
    Figure 5. United States Erythropoietin Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Erythropoietin Drugs Market Size 2017-2028 (US$ Million)
    Figure 7. United States Erythropoietin Drugs Sales 2017-2028 (K Pcs)
    Figure 8. United States Erythropoietin Drugs Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Erythropoietin Drugs Market Share in Global, in Volume (K Pcs) 2017-2028
    Figure 10. Erythropoietin Drugs Report Years Considered
    Figure 11. Product Picture of Epoetin-alfa
    Figure 12. Product Picture of Darbepoetin-alfa
    Figure 13. Product Picture of Epoetin-beta
    Figure 14. Product Picture of Others
    Figure 15. Global Erythropoietin Drugs Market Share by Type in 2022 & 2028
    Figure 16. Global Erythropoietin Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 17. Global Erythropoietin Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 18. Global Erythropoietin Drugs Sales by Type (2017-2028) & (K Pcs)
    Figure 19. Global Erythropoietin Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 20. Global Erythropoietin Drugs Price by Type (2017-2028) & (USD/Pcs)
    Figure 21. United States Erythropoietin Drugs Market Share by Type in 2022 & 2028
    Figure 22. United States Erythropoietin Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 23. United States Erythropoietin Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 24. United States Erythropoietin Drugs Sales by Type (2017-2028) & (K Pcs)
    Figure 25. United States Erythropoietin Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 26. United States Erythropoietin Drugs Price by Type (2017-2028) & (USD/Pcs)
    Figure 27. Product Picture of Anemia
    Figure 28. Product Picture of Kidney Disorders
    Figure 29. Product Picture of Other
    Figure 30. Global Erythropoietin Drugs Market Share by Application in 2022 & 2028
    Figure 31. Global Erythropoietin Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 32. Global Erythropoietin Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 33. Global Erythropoietin Drugs Sales by Application (2017-2028) & (K Pcs)
    Figure 34. Global Erythropoietin Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 35. Global Erythropoietin Drugs Price by Application (2017-2028) & (USD/Pcs)
    Figure 36. United States Erythropoietin Drugs Market Share by Application in 2022 & 2028
    Figure 37. United States Erythropoietin Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 38. United States Erythropoietin Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 39. United States Erythropoietin Drugs Sales by Application (2017-2028) & (K Pcs)
    Figure 40. United States Erythropoietin Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 41. United States Erythropoietin Drugs Price by Application (2017-2028) & (USD/Pcs)
    Figure 42. North America Erythropoietin Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 43. North America Erythropoietin Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 44. U.S. Erythropoietin Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Canada Erythropoietin Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Europe Erythropoietin Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 47. Europe Erythropoietin Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 48. Germany Erythropoietin Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. France Erythropoietin Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. U.K. Erythropoietin Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Italy Erythropoietin Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Russia Erythropoietin Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Asia-Pacific Erythropoietin Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 54. Asia-Pacific Erythropoietin Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 55. China Erythropoietin Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Japan Erythropoietin Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. South Korea Erythropoietin Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. India Erythropoietin Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Australia Erythropoietin Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Taiwan Erythropoietin Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Indonesia Erythropoietin Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Thailand Erythropoietin Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Malaysia Erythropoietin Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Philippines Erythropoietin Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Latin America Erythropoietin Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 66. Latin America Erythropoietin Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 67. Mexico Erythropoietin Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Brazil Erythropoietin Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Argentina Erythropoietin Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Middle East & Africa Erythropoietin Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 71. Middle East & Africa Erythropoietin Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 72. Turkey Erythropoietin Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Saudi Arabia Erythropoietin Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. UAE Erythropoietin Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. Erythropoietin Drugs Value Chain
    Figure 76. Erythropoietin Drugs Production Process
    Figure 77. Channels of Distribution
    Figure 78. Distributors Profiles
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed